What is the primary purpose of 503B outsourcing facilities?

• A. To fulfill all patient-specific prescriptions
• B. To alleviate shortages by producing compounded products for office use when documented as in short supply
• C. To replace traditional compounding pharmacies
• D. To supply only to retail community pharmacies

Answer: (B)

503B outsourcing facilities exist to address shortages by producing sterile compounded products for use in healthcare settings when a shortage is documented. They ship to offices, clinics, and hospitals to help fill gaps in supply, rather than fulfilling individual patient prescriptions or replacing traditional compounding pharmacies. These facilities operate under FDA oversight and CGMP, focusing on large-batch production of office-use products to support healthcare facilities during shortages. The other options don’t fit because traditional compounding for patient-specific prescriptions is handled by 503A pharmacies, outsourcing facilities aren’t meant to replace traditional compounding, and their primary role isn’t limited to supplying retail community pharmacies.